Medical Science
Pancreatic Cancer Pill Daraxonrasib Shows Striking Promise Against RAS-Mutant Lung Cancer
A pill approved only days ago for one of the deadliest forms of pancreatic cancer is now generating excitement for an entirely different disease. Daraxonrasib, sold under the brand name Rasonque, produced tumor responses in more than 30% of patients with previously treated, advanced RAS-mutant non-small cell lung